Call for time limits on PHARMAC's drug assessment process

4 February 2024 - The Cancer Society says it is great to see the new government invest in cancer drugs, ...

Read more →

Comparison of PHARMAC with UK agency was misleading

17 December 2019 - The Broadcasting Standards Authority has upheld part of a complaint that an interview on Radio New ...

Read more →

Proposal to widen access to etanercept and award sole supply

3 May 2019 - PHARMAC is proposing to make changes to the funding of etanercept, a biologic medicine used to ...

Read more →

Subsidised access to new melanoma drugs: in need of further innovation?

19 August 2016 - New Zealand is now the melanoma capital of the world but is behind the rest of ...

Read more →